7XJ Stock Overview
Provides life insurance products and services in Japan, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 7XJ from our risk checks.
Lifenet Insurance Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥12.00 |
| 52 Week High | JP¥12.00 |
| 52 Week Low | JP¥6.00 |
| Beta | 0.66 |
| 11 Month Change | 9.09% |
| 3 Month Change | 18.81% |
| 1 Year Change | 100.00% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 40.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7XJ | DE Insurance | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.1% | -0.5% |
| 1Y | 100.0% | 23.5% | 8.3% |
Return vs Industry: 7XJ exceeded the German Insurance industry which returned 23.5% over the past year.
Return vs Market: 7XJ exceeded the German Market which returned 8.3% over the past year.
Price Volatility
| 7XJ volatility | |
|---|---|
| 7XJ Average Weekly Movement | 5.4% |
| Insurance Industry Average Movement | 2.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 7XJ has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 7XJ's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 224 | Ryosuke Mori | www.lifenet-seimei.co.jp |
Lifenet Insurance Company provides life insurance products and services in Japan, North America, and internationally. It offers term life, whole life medical, cancer, and disability insurance products. The company sells its products and services directly to customers through the Internet.
Lifenet Insurance Company Fundamentals Summary
| 7XJ fundamental statistics | |
|---|---|
| Market cap | €994.36m |
| Earnings (TTM) | €36.05m |
| Revenue (TTM) | €160.77m |
27.6x
P/E Ratio6.2x
P/S RatioIs 7XJ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7XJ income statement (TTM) | |
|---|---|
| Revenue | JP¥26.11b |
| Cost of Revenue | JP¥17.24b |
| Gross Profit | JP¥8.88b |
| Other Expenses | JP¥3.02b |
| Earnings | JP¥5.86b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 72.90 |
| Gross Margin | 33.99% |
| Net Profit Margin | 22.42% |
| Debt/Equity Ratio | 0% |
How did 7XJ perform over the long term?
See historical performance and comparison